ARTICLE | Clinical News
MYK-491: Ph I started
February 22, 2017 2:05 AM UTC
MyoKardia began a placebo-controlled Phase I trial to evaluate single ascending doses of oral MYK-491 in healthy volunteers. Sanofi and MyoKardia are partnered to co-develop the biotech’s therapies f...
BCIQ Target Profiles